the previous demonstration of the efficacy and tolerability of the oka strain of varicella-zoster virus ( vzv ) in clinical trials involving vaccination of both normal and immunocompromised individuals has laid the foundation for its use in preventing chickenpox .
C0042338
varicella-zoster virus
C0008049
chickenpox